Subsequently, through literature reviews about EGR1, JUN, and EZH2, we recognized that EGR1 and JUN could be tumor suppressors, whereas EZH2 can inhibit the expression of tumor suppressors (Baron et al., 2006; Shaulian, 2010; Eich et al., 2020). Here, JUN is linked to neoplasm.